To gain in-depth knowledge with respect to the possible correlation between the expression level of BCAP31 and the prognosis of tumor patients undergoing immunotherapy, we analyzed it in order to examine the variances in therapeutic response and prognosis across various subgroups of BCAP31 expression. The gene discussed is BCAP31; the disease is neoplasm.